Navidea is a leader in precision medicine with products and product candidates designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. We have a deep understanding of and experience translating CD206 targeting technology, particularly in the area of radiopharmaceuticals, into novel products to advance patient care.